Inhibition of interleukin-6 signalling improves insulin sensitivity and reduces lipoprotein (a) levels in humans - Schultz, O; Oberhauser, F; Saech, J; Rubbert-Roth, A; Krone, W; Laudes, M (PLoS One, 2010)